William Martin
Internal Medicine · Lawrenceville, GANPI 1417095340
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.3% of the total across 293 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 25 manufacturers, the largest accounting for just 18.2% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2020 at $1,294 and has fallen 62.3% since, to $488 in 2023.
Across 293 payments — averaging $17.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$908
- AstraZeneca$501
- Novo Nordisk$499
- Sanofi-aventis U.S. LLC$442
- Amarin Pharma, Inc.$410
- AbbVie$362
- plus $2K from 19 others
What the payments were for
- Food & beverage$4,96699%
- Education$361%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen(2 entities) | 51 | $908 |
| AstraZeneca | 33 | $501 |
| Novo Nordisk | 35 | $499 |
| Sanofi-aventis U.S. LLC | 24 | $442 |
| Amarin Pharma, Inc. | 27 | $410 |
| AbbVie(2 entities) | 17 | $362 |
| Bayer | 21 | $342 |
| Lilly USA, LLC | 15 | $244 |
| Esperion Therapeutics, Inc. | 11 | $185 |
| Abbott | 7 | $159 |
| Boehringer Ingelheim | 7 | $127 |
| Novartis | 8 | $115 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 6 | $108 |
| Xeris Pharmaceuticals, Inc. | 4 | $77 |
| Merck | 5 | $74 |
| Pfizer | 4 | $65 |
| Johnson & Johnson(2 entities) | 3 | $60 |
| GSK | 4 | $58 |
| Scilex Pharmaceuticals Inc. | 1 | $57 |
| Avanir Pharmaceuticals, Inc. | 3 | $55 |
| Kaleo, Inc. | 1 | $53 |
| Regeneron Healthcare Solutions, Inc. | 2 | $42 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $31 |
| Dexcom, Inc. | 1 | $14 |
| Aegerion Pharmaceuticals, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Repatha$116
How this compares
$5,002 in reported general payments places this provider in the 85th percentile of 3,311 internal medicine providers in Georgia.
Other internal medicine in Lawrenceville
- Christopher CrookerLawrenceville$19K
- Michael GibsonSmyrna$2.2M
- Eduard FatakhovAlpharetta$376K
- Tracey HenryAtlanta$305K
- Sharon TuckettVilla Rica$265K
- Ebon BourneMarietta$242K
- Jennifer WoehlerSavannah$207K
- Julian HutchinsGreensboro$201K
- Brian PearlmanDalton$199K
- Scott ParryAtlanta$162K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.